Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Deloitte
Johnson and Johnson
McKinsey
Express Scripts
Healthtrust
Boehringer Ingelheim
Medtronic
Fish and Richardson

Generated: August 16, 2018

DrugPatentWatch Database Preview

Solvay Company Profile

« Back to Dashboard

What is the competitive landscape for SOLVAY, and what generic and branded alternatives to SOLVAY drugs are available?

SOLVAY has sixty-three approved drugs.



Summary for Solvay
US Patents:0
Tradenames:45
Ingredients:34
NDAs:63
Patent Litigation for Solvay: See patent lawsuits for Solvay

Drugs and US Patents for Solvay

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay DEXONE 0.75 dexamethasone TABLET;ORAL 084993-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Solvay CIN-QUIN quinidine sulfate TABLET;ORAL 084932-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Solvay GYNOREST dydrogesterone TABLET;ORAL 017388-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Solvay UNIPRES hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 085893-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Solvay R-P MYCIN erythromycin TABLET, DELAYED RELEASE;ORAL 061659-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Solvay ZIDE hydrochlorothiazide TABLET;ORAL 083925-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Solvay SER-A-GEN hydralazine hydrochloride; hydrochlorothiazide; reserpine TABLET;ORAL 087210-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Solvay

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-001 Dec 5, 1994 4,085,225 ➤ Sign Up
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-003 Dec 5, 1994 4,085,225 ➤ Sign Up
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-002 Dec 5, 1994 4,085,225 ➤ Sign Up
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-004 Dec 5, 1994 4,085,225 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Boehringer Ingelheim
Express Scripts
Mallinckrodt
Daiichi Sankyo
Cipla
Healthtrust
Farmers Insurance
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.